Where Tourism Brings Pricey Health Care, Locals Fight Back
Residents in Colorado ski resort country found relief from high insurance premiums and high hospital costs by joining forces and negotiating prices directly with the local hospital.
Health Industry
1,941-1,960 of 4,017 results
-
-
KHN鈥檚 鈥榃hat The Health?鈥: Gun Violence And The Politics Of Public Health
The recent tragic mass shootings have refocused efforts to treat gun violence as a public health issue rather than strictly a law enforcement problem. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Mary Agnes Carey of Kaiser Health News join KHN鈥檚 Julie Rovner to discuss this, plus the health implications of the budget deal passed by Congress and signed by President Donald Trump, as well as reaction from Canada to a proposal to allow broader imports of its prescription drugs. Plus, for 鈥渆xtra credit,鈥 the panelists recommend their favorite health stories of the week.
-
Price Of Snakebite Drug Is Sky High, But New Competitor Unlikely To Lower Costs
The drug CroFab, which has been on the market since 2000, now faces competition from a drug called Anavip. But both are expensive.
-
Federal Experts鈥 Advice On HPV Vaccine Could Leave Adults Confused
A federal advisory panel says people between ages 27 and 45 may benefit from the vaccine to fight the human papillomavirus. But some public health advocates worry that the advice doesn鈥檛 provide doctors and patients clear guidance about who in this large age group are good candidates for the vaccine.
-
Doctors Argue Plans To Remedy Surprise Medical Bills Will 鈥楽hred鈥 The Safety Net
A case of questionable logic.
By Rachel Bluth -
Watch: What Happened To That $500K Dialysis Bill
After journalists investigate, Fresenius, one of the largest dialysis providers in the U.S., has agreed to waive a half-million-dollar bill. Sovereign Valentine, from Plains, Mont., said it鈥檚 a 鈥渉uge relief.鈥
-
Drugmakers Master Rolling Out Their Own Generics To Stifle Competition
Known as 鈥渁uthorized generics,鈥 in-house spinoffs of brand-name drugs quietly undermine the competition.
By Jay Hancock and Sydney Lupkin -
Superstar Athletes Popularize Unproven Stem Cell Procedures
Treatments for baseball pitcher Max Scherzer and other pros may mislead fans about costly, controversial, unapproved stem cell shots.
By Liz Szabo -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don鈥檛 have to.
-
Infusion Treatments 鈥 Needed or Not 鈥 Can Deplete Patients鈥 Wallets
When it comes to physician-administered infusion drugs, doctors sometimes have a financial reason for their choice and patients often aren鈥檛 aware of cheaper options.
-
Podcast
KHN鈥檚 鈥榃hat The Health?鈥: Deciphering The Democrats鈥 Health Debate
Health care was a major topic at the Democratic presidential candidate debates in Detroit on Tuesday and Wednesday, but the focus on plan minutiae may have left viewers more confused than edified. Alice Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Caitlin Owens of Axios join KHN鈥檚 Julie Rovner to discuss the points made by the candidates plus a series of Trump administration health initiatives on drug prices and hospital shopping.
-
California Bill Would Fight Deals That Delay Generic Drugs
As California Attorney General Xavier Becerra cracks down on pharmaceutical companies he said paid competitors to delay generic versions of their drugs, he鈥檚 also pushing for legislation that would give his department tools to catch more of them. It鈥檚 the first of its kind in the nation.
-
Trump Administration 鈥極pen For Business鈥 On Drug Imports From Canada
HHS secretary announces a preliminary plan Wednesday to allow Americans to import certain lower-cost drugs from Canada. Manufacturers were quick to criticize the plan, saying it does not guarantee the safety of drugs coming into the country.
-
Trump Administration Moves To Make Health Care Costs More Transparent
The proposed rules would require hospitals to provide far more detail about the actual prices they charge insurers for patients鈥 care.
-
In A Messy Democratic Presidential Debate, Facts About ‘Medicare For All’ Get Tossed About
Candidates used their varying views on how to achieve universal coverage 鈥 whether through Medicare for All or more incremental steps 鈥 as a means to differentiate themselves from the field.
-
‘If You Like Your Plan, You Can Keep It.’ Biden鈥檚 Invokes Obama’s Troubled Claim.
The health policy landscape is very different than it was when Barack Obama made this pledge as part of his pitch for the Affordable Care Act. But the words still might be risky for Democratic presidential primary hopeful Joe Biden.
-
Creator Of Brain Exam That Trump Aced Demands New Training For Testers
Geriatricians are outraged over a new requirement to pay for training in order to administer the MoCA test, a widely used tool to screen for cognitive problems. The test鈥檚 creator said he was worried about accuracy and liability.
-
Doctor Alexa Will See You Now: Is Amazon Primed To Come To Your Rescue?
Amazon, along with a host of other technology companies, is working on ways to use its smart speaker devices to bring a range of health care services into your home.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
They May Owe Nothing 鈥 Half-Million-Dollar Dialysis Bill Canceled
After reporting by KHN, NPR and CBS, Fresenius has agreed to waive a Montana man鈥檚 huge bill for out-of-network dialysis care.
By Jenny Gold